Code Biotherapeutics pulls in $75m Series A

Code Biotherapeutics, a biotech firm, has raised $75 million in Series A financing.

7 June 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Healthcare Briefs